TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
QGEN

Qiagen NV

Healthcare · Diagnostics & Research

44.80$ +3.3% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

Qiagen NV (QGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 535 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement QGEN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
476 509 459 496 502 521 483 534 533 540 492 535 2,100
178 193 168 462 194 188 175 199 201 223 183 195 802
298 316 291 35 308 333 309 334 331 317 310 340 1,299
48 46 51 49 44 49 44 48 49 47 48 50 195
29 28 28 29 29 28 32 31 30 33 28 30 121
201 205 196 263 196 214 193 212 202 163 193 208 766
97 111 95 -228 112 119 115 122 129 154 117 132 532
13 12 10 11 11 11 7.3 7.6 8.2 10 11 10 39
100 119 102 -223 116 126 120 127 135 109 86 132 462
22 21 22 -40 18 38 29 31 4.7 1.3 18 29 53
78 98 81 -183 98 88 91 96 130 108 68 103 409
163 183 167 -159 178 183 171 184 277 169 148 142 736

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?